Cash And Equivalent Изменить Дата
Acadia Pharmaceuticals USD 188.66M 90.46M 2023-12
Agios Pharmaceuticals USD 88.2M 23.87M 2023-12
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
Amgen USD 10.94B 23.8B 2023-12
Avrobio USD 105.84M 18.85M 2023-09
BioCryst Pharmaceuticals USD 397.59M 251.38M 2023-09
Biogen USD 1.05B 1.24B 2023-12
BioMarin Pharmaceutical USD 755.13M 30.29M 2023-12
Bluebird Bio USD 165.35M 7.52M 2023-09
Capricor Therapeutics USD 8.98M 852K 2023-09
Daiichi Sankyo JPY 590.77B 71.1B 2023-09
Eli Lilly USD 2.38B 313.7M 2023-09
Esperion Therapeutics USD 114.83M 23.64M 2023-09
Gilead Sciences USD 8.43B 2.72B 2023-12
Incyte USD 3.21B 13.85M 2023-12
Insmed USD 482.37M 4.74M 2023-12
Ionis Pharmaceuticals USD 399.27M 47.21M 2023-12
Lumos Pharma USD 35.56M 2.3M 2023-09
Moderna USD 2.91B 25M 2023-12
Nektar Therapeutics USD 64.92M 14.19M 2023-09
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
Novavax USD 651.1M 145.19M 2023-09
Pfizer USD 3.15B 516M 2023-09
PTC Therapeutics USD 594M 428.84M 2023-12
Regeneron Pharmaceuticals USD 16.24B 14.09B 2023-12
Roche Holding CHF 3.72B 1.27B 2023-06
Sarepta Therapeutics USD 541.93M 310M 2023-09
Ultragenyx Pharmaceutical USD 777.11M 704.54M 2023-12
Vertex Pharmaceuticals USD 11.11B 959.1M 2023-09



Sarepta Therapeutics Денежные Средства И Эквиваленты - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.